Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689801010 | Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689802015 | Ispaghula husk 3.5 g and mebeverine hydrochloride 135 mg granules for oral suspension sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Product containing mebeverine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Product containing mebeverine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has active ingredient | Mebeverine hydrochloride (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has manufactured dose form | Granules | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Product containing ispaghula husk and mebeverine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has active ingredient | Ispaghula husk (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has active ingredient | Antilipemic agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral granules | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has active ingredient | Mebeverine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Product containing mebeverine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Mebeverine hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has precise active ingredient | Mebeverine hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength numerator value | 135 | false | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has unit of presentation | Sachet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength numerator value | 3.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Ispaghula husk (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has manufactured dose form | Granules for oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has precise active ingredient | Ispaghula husk (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Plays role | Laxative therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) | Is a | Ispaghula husk and mebeverine only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR